Study on Pharmacokinetics of Evodiamine and Rutaecarpine in Rabbit

Lian-jun LUAN,Guo-li QIU,Yi-yu CHENG
DOI: https://doi.org/10.3321/j.issn:1001-2494.2006.01.015
2006-01-01
Abstract:OBJECTIVE To establish a liquid chromatography-electrospray mass spectrometry (LC/ESI-MS) method for the determination and pharmacokinetic study of evodiamine, rutaecarpine in rabbits. METHODS Evodiamine and rutaecarpine in rabbits plasma at different sampling time were determined by HPLC/MS. The plasma samples were deproteined by methanol.The separation was performed on an Agilent Zorbax SB-C18 column with acetonitrile-2% tetrahydorfuran (62:38) as the mobile phase at the flow rate of 0.5 mL·min . Electrospray ionization source (ESI) was applied and operated in the negative ion mode. The m/z 302 (evodiamine, [M - H] - ), m/z 286 (rutaecarpine , [ M - H ] - ) and 595 ( rutaecarpine, [ 2M + Na - 2H ] - ) were used to quantify evodiamine and rutaecarpine respectively using the selected ion monitoring (SIM) mode. The pharmacokinetic parameters were calculated with 3P87 pharmacokinetic program.RESULTS The linear range was 0.32-32.0 and 1.0-40.0 μg·L-1 for evodiamine and rutaecarpine, respectively. The average extraction recoveries were all over 80% . The inter- and intra-day precisions (RSD) were all less than 5% ( n = 6) . The concentration-time curves of evodiamine and rutaecarpine were fitted to an one-compartment model. The total areas under the plasma concentration-time curve (AUC) were (183.2±76.2) and (453.5±191.0)μg·min·L-1 for evodiamine and rutaecarpine, respectively.The plasma clearances ( CLs) of evodiamine and rutaecarpine were (47.2±29.0) and (41.4±23.3) L·kg-1·min-1, respectively.CONCLUSION The method is simple, rapid and sensitive. It is proved to be suitable for pharmacokinetic studies of evodiamine and rutaecarpine.
What problem does this paper attempt to address?